Clinical Trials in Maryland

Showing 19461-19480 of 23,284 trials

Systemic and Local Diffusion of Ethanol After Administration of Ethanol 96% Formulated in a Gel and Ethanol 98% Solution by the Percutaneous Route, in Patients With Congenital Venous Malformations:Pharmacokinetic, Pharmacodynamic and Clinical Study.

NCT00462462

Absolute ethanol has been used "off-label" as an unmodified formulation (solution) in Congenital Venous Malformations (CVM). Despite its effectiveness, absolute ethanol appears difficult to handle because of its high diffusion capacity outside the CVM and in the blood circulation. A less diffusible ethanol-based product (ethanol gel) has been developed in order to minimize systemic and local diffusion capacities of ethanol. Therefore, the pharmacokinetic parameters and their clinical and paraclinical outcomes between ethanol gel 96% and absolute ethanol need to be carried out. FDA Office of Orphan Products Development (FDA OOPD) : Funding source.

Congenital Venous Malformation

Orfagen32 participantsStarted May 2007

Baltimore, Maryland, United States • Tours, France

COMPLETEDPhase 2/319 miles

Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Skin Infections

NCT01400867

This is a study of safety, effectiveness, blood levels and tolerance of Ceftaroline fosamil in children with skin infections receiving antibiotic therapy in the hospital.

Infections, Pediatrics

Forest Laboratories163 participantsStarted Dec 2011

Phoenix, Arizona, United States • Orange, California, United States • San Diego, California, United States +68 more locations

Systemic and Local Diffusion of Ethanol After Administration of Ethanol 96% Formulated in a Gel and Ethanol 98% Solution by the Percutaneous Route, in Patients With Congenital Venous Malformations:Pharmacokinetic, Pharmacodynamic and Clinical Study.

Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Skin Infections

Find Trials by Condition in Maryland

Cradling Our Future Through Family Strengthening Study

Entry Into Comprehensive Methadone Treatment Via Interim Maintenance

Identification of a Plasma Proteomic Signature for Lung Cancer

Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer Tumors

RAMP 200 / RAMP Cardiovascular Tests at the Point-of-Care

Study to Evaluate the Efficacy and Safety of Dronabinol Metered Dose Inhaler (MDI) in Acute Treatment of Migraine Headache

Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Efficacy Study of Sublingual Immunotherapy to Treat Ragweed Allergies

Cetuximab in Treating Patients With Persistent or Recurrent Cervical Cancer

Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Community Acquired Bacterial Pneumonia (CABP)

A Clinical Demonstration of EEG Brain-computer Interface for ALS Patients

A Study of DER 45-EV Gel to Treat Rosacea

Efficacy Study of a ZT-1 Implant in Patients Suffering From Alzheimer's Disease

A Phase I Study of MGCD0103 Given Three-Times Weekly In Patients With Leukemia Or Myelodysplastic Syndromes

Optimal Anti-tachycardia Therapy in Implantable Cardioverter-defibrillator (ICD) Patients Without Pacing Indications

Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Male Subjects

Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female Subjects